Announced Tue, 19 May · 17:17 IST

The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Interface Financial Services Ltd

Creeping Acquisition Near ThresholdOwnership Changes View source PDF

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
-7.7%1-day move
₹0.39
prior close
₹0.39
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-2.6-2.6+0.0-2.6-7.7-5.1-7.7-7.7-7.7-10.3-12.8-15.4-17.9
Up moveDown movePending
AI summary

Interface Financial Services Limited, a non-promoter entity, filed a disclosure under SEBI SAST Regulations for an open market transaction on 18.05.2026. The filing shows the acquirer held 84,000,000 shares (9.31%) before the transaction, acquired 40,303,000 shares (4.47%), and reported a post-transaction holding of 43,697,000 shares (4.84%). The target company's total share capital is 90,260,300 shares of Rs. 2 each. Notably, the acquirer is classified as NOT belonging to the Promoter/Promoter group, indicating this is a substantial acquisition by an external party rather than an insider or promoter transaction.

Likely market impact

This represents a significant share acquisition by a non-promoter entity in the open market, crossing the 5% threshold proximity. Shareholders should note that an entity outside the promoter group has substantially increased its stake, which could signal potential change in control dynamics or strategic interest in Biogen Pharmachem.